These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 17194833

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasmodium vivax in the Democratic Republic of East Timor: Parasite prevalence and antifolate resistance-associated mutations.
    de Almeida A, Rosário VE, Henriques G, Arez AP, Cravo P.
    Acta Trop; 2010 Sep; 115(3):288-92. PubMed ID: 20412783
    [Abstract] [Full Text] [Related]

  • 5. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
    Hastings MD, Maguire JD, Bangs MJ, Zimmerman PA, Reeder JC, Baird JK, Sibley CH.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):733-40. PubMed ID: 15673758
    [Abstract] [Full Text] [Related]

  • 6. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
    Alifrangis M, Lemnge MM, Rønn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC.
    Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F, Herrera S, Murrain B, Gutiérrez A, Moreno LA, Manzano M, Muñoz A, Plowe CV.
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.
    Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev V, Kumar A, Ansari MA, Sharma YD.
    Antimicrob Agents Chemother; 2004 Mar; 48(3):879-89. PubMed ID: 14982779
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.
    Ahmed A, Lumb V, Das MK, Dev V, Wajihullah, Sharma YD.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3934-8. PubMed ID: 16982787
    [Abstract] [Full Text] [Related]

  • 13. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
    Hastings MD, Porter KM, Maguire JD, Susanti I, Kania W, Bangs MJ, Sibley CH, Baird JK.
    J Infect Dis; 2004 Feb 15; 189(4):744-50. PubMed ID: 14767830
    [Abstract] [Full Text] [Related]

  • 14. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY, Detering C, Varani G, Jacobus DP, Schiehser GA, Shieh HM, Nevchas I, Terpinski J, Sibley CH.
    Mol Biochem Parasitol; 2005 Dec 15; 144(2):198-205. PubMed ID: 16181688
    [Abstract] [Full Text] [Related]

  • 15. Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
    Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Safi N, Butt W, Atta H, Djadid ND.
    Malar J; 2010 Mar 14; 9():75. PubMed ID: 20226087
    [Abstract] [Full Text] [Related]

  • 16. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
    Djapa LY, Basco LK, Zelikson R, Rosowsky A, Djaman JA, Yonkeu JN, Bolotin-Fukuhara M, Mazabraud A.
    Mol Biochem Parasitol; 2007 Nov 14; 156(1):89-92. PubMed ID: 17727978
    [Abstract] [Full Text] [Related]

  • 17. Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.
    Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH.
    Malar J; 2008 Apr 28; 7():72. PubMed ID: 18442404
    [Abstract] [Full Text] [Related]

  • 18. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.
    Am J Trop Med Hyg; 2003 Dec 28; 69(6):601-6. PubMed ID: 14740875
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S, Leartsakulpanich U, Taweechai S, Tarnchompoo B, Kamchonwongpaisan S, Yuthavong Y.
    Antimicrob Agents Chemother; 2006 Nov 28; 50(11):3631-7. PubMed ID: 16954316
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.